Jonathan P. Siegrist is the Executive Vice President of Research and Development (R&D) and Chief Technology Officer (CTO) at QuidelOrtho Corp, a global leader in in vitro diagnostics. With an extensive background in the medical technology and diagnostics industry, Siegrist has been instrumental in driving innovation and growth at QuidelOrtho. Prior to his current role, he held various leadership positions within the company, showcasing his deep understanding of the industry and commitment to advancing diagnostic solutions. As EVP of R&D and CTO, Siegrist is responsible for overseeing the development and implementation of cutting-edge diagnostic technologies that improve patient outcomes and enhance healthcare delivery. His strategic vision and technical expertise have been crucial in expanding QuidelOrtho's product portfolio and strengthening its position in the market. Under his leadership, the company has successfully launched several groundbreaking diagnostic assays and platforms, solidifying its reputation as an innovator in the field. Siegrist's achievements at QuidelOrtho are a testament to his dedication to advancing the field of in vitro diagnostics. His ability to foster collaboration between cross-functional teams and drive the development of novel technologies has been key to the company's success. As QuidelOrtho continues to grow and evolve, Siegrist's role as EVP of R&D and CTO will remain pivotal in shaping the future of diagnostics and improving global health outcomes.